NCT04526756 is a NA clinical trial of Mechanical Thrombectomy in Ischemic Stroke, sponsored by Shanghai East Hospital.

Who is sponsoring NCT04526756?

NCT04526756 is sponsored by Shanghai East Hospital.

What drugs are being tested in NCT04526756?

Interventions in NCT04526756: Mechanical Thrombectomy.

What condition does NCT04526756 study?

NCT04526756 studies Ischemic Stroke, Acute Stroke.

Is NCT04526756 still recruiting?

NCT04526756 is currently completed. Last updated 26 August 2020.

Last reviewed 2020-08-26 · How we verify

NCT04526756

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke With Mild Symptoms

Completed NA Last updated 26 August 2020

What this trial tests

NA trial testing Mechanical Thrombectomy in Ischemic Stroke in 105 participants. Completed in 20 June 2020.

Timeline

1 July 2016

Primary endpoint
15 March 2020

20 June 2020

Quick facts

Lead sponsor	Shanghai East Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	105
Start date	1 July 2016
Primary completion	15 March 2020
Estimated completion	20 June 2020
Sites	1 location across China

Drugs / interventions tested

Mechanical Thrombectomy — full drug profile →

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →
Acute Stroke — all drugs for Acute Stroke →

Sponsor

Shanghai East Hospital

Who can join

18 and older, any sex, with Ischemic Stroke or Acute Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mechanical thrombectomy(MT) has been recommended in patients with acute large vessel occlusion stroke(LVO) , especially for those with National Institutes of Health Stroke Scale (NIHSS) score ≥6. However, it is still unclear if patients with minor strokes and LVO also benefit from MT.The aim of this study was to evaluate the safety and efficacy of MT for acute LVO and mild symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mechanical Thrombectomy for Acute Stroke Due to Large-Vessel Occlusion Presenting With Mild Symptoms.
Liu F, Shen H, Chen C, Bao H, et al · · 2021 · cited 7× · PMID 34777207 · DOI 10.3389/fneur.2021.739267

Verify or expand the search:

Other trials of Mechanical Thrombectomy

Trials testing the same drug.

NCT07356284 — Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis · Phase 3 · not yet recruiting
NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
NCT06236828 — The MRI-based Evaluation of Safety and Efficacy of EVT and SMT: A Retrospective, Multicenter Study · completed
NCT05030142 — Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion · NA · unknown
NCT04479020 — REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio® · completed

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Shanghai East Hospital trials

Trials by the same sponsor.

NCT07519161 — Pharmacological Intervention to Prevent NOAF After TAVR · NA · not yet recruiting
NCT07516223 — MRI-Assisted Guidance for Non-Essential Tissue Sampling · NA · not yet recruiting
NCT07279259 — Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management · Phase 2 · recruiting
NCT07294495 — Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Tr · NA · not yet recruiting
NCT07290816 — Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04526756 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai East Hospital
Last refreshed: 26 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04526756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing